OMA CHOORANAM IN THE MANAGEMENT OF MOOLAM

AN OPEN NON RANDOMISED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF OMA CHOORANAM IN THE MANAGEMENT OF MOOLAM ( INTERNAL HEMORRHOIDS) AMONG OUT-PATIENTS ATTENDING AYOTHIDOSS PANDITHAR HOSPITAL,NATIONAL INSTITUTE OF SIDDHA,CHENNAI

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039973

Enrollment

Registered

2022-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K649- Unspecified hemorrhoids Health Condition 2: K649- Unspecified hemorrhoids

Interventions

Intervention1: OMA CHOORANAM: Dosage: 3 grams twice a day after food Adjuvant: Warm water Duration of treatment: 24 days (1/2 mandalam) Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-60 Years Sex Male, Female, Transgender Patients having any of the symptoms like bleeding during defecation, constipation, pain in anal region will be selected. Second degree Hemorrhoids Patients Willing to give blood samples for the investigations when require and undergo examination using proctoscopy Patient willing to sign informed consent

Exclusion criteria

Exclusion criteria: Fissure in Ano Fistula in Ano External Hemorrhoids K/H/O Rectal tuberculosis K/H/O Rectal cancer

Design outcomes

Primary

Measure	Time frame
Improvement of Hemorrhoid Symptom Scoring (HSS) before and after treatment Proctoscopic examination Ã¢â?¬â??Whether Pile mass is reduced or not Timepoint: 25 th day	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K Bharathy

National Institute of Siddha Tambaram Sanatorium

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026